Ljubljana, Ljubljana, Slovenia
As Associate Director of Science and Technology at Novartis since 2021, I serve as the Innovation Strategy Lead within Technical Development and Research, Biologics. With over 20 years of experience, my focus lies in combining scientific expertise with business strategy to expedite the evaluation, adoption, and scaling of cutting-edge technologies that align with organizational goals. My core competencies include analytics, project management, and pharmacology, which I have applied to advance biologics R&D, including protein engineering, bioconjugation, and delivery technologies. I am committed to driving innovation and enabling impactful solutions that address complex challenges in biopharmaceutical development.
Associate Director, Science & Technology – Innovation Strategy Lead The Innovation Strategy Lead serves as a strategic catalyst for innovation within the Technical Development and Research, Biologics. This role bridges deep scientific insight with business strategy to accelerate the evaluation, adoption, and scaling of new technologies in alignment with the company’s ambitions.
Development and evaluation of new technologies in the field of protein modification (half life extension of biopharmaceuticals, non invasive delivery systems for biopharmaceuticals)
Biopharmaceuticals, Development of biosimilars, Non-invasive drug delivery systems for biological drugs
Conducting a research on novel delivery vehicles for oral administration of protein therapeutics.